Deutsche Bank initiated coverage on Waystar Holding Corp. with a new price target
$WAY
EDP Services
Technology
Deutsche Bank initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $27.00
Get the next $WAY alert in real time by email
Get the next $WAY alert in real time by email
Chat with this insight
Save time and jump to the most important pieces.
Recent Analyst Ratings for $WAY
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/14/2025 | $45.00 | Buy | Truist |
| 2/11/2025 | $51.00 | Buy | Jefferies |
| 11/22/2024 | $40.00 | Outperform → Strong Buy | Raymond James |
| 7/2/2024 | $27.00 | Buy | BofA Securities |
| 7/2/2024 | $24.00 | Overweight | Barclays |
| 7/2/2024 | $27.00 | Buy | Deutsche Bank |
| 7/2/2024 | $32.00 | Buy | Goldman |
| 7/2/2024 | $24.00 | Overweight | JP Morgan |
Waystar to Announce First Quarter 2025 Financial Results on April 30, 2025
LEHI, Utah and LOUISVILLE, Ky., April 7, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the first quarter ended March 31, 2025, after market close on Wednesday, April 30, 2025. The company will discuss its financial results on a conference call at 4:30 p.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. The webcast will be arc
Ardent Health Appoints Robert DeMichiei to Board of Directors
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U
New research reveals that investing in AI and advanced automation is a top 2025 priority for RCM leaders
92% of leaders rank AI and advanced automation as a key focus for overcoming industry challenges Patient Access and Claim Management emerge as the top RCM functions prioritized for automation investment LEHI, Utah and LOUISVILLE, Ky., March 4, 2025 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced the results of a comprehensive Qualtrics market survey identifying the top revenue cycle management (RCM) trends of 2025. The study surveyed 600 healthcare RCM, finance, and technology leaders from provider organizations of all types and sizes. The findings show that decision-makers are actively prioritizing AI and advanced automation to addres
Truist initiated coverage on Waystar Holding Corp. with a new price target
Truist initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $45.00
Jefferies initiated coverage on Waystar Holding Corp. with a new price target
Jefferies initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $51.00
Waystar Holding Corp. upgraded by Raymond James with a new price target
Raymond James upgraded Waystar Holding Corp. from Outperform to Strong Buy and set a new price target of $40.00
Chairperson Driscoll John Patrick was granted 8,695 shares and bought $129,000 worth of shares (6,000 units at $21.50), increasing direct ownership by 21% to 85,623 units (SEC Form 4)
4 - Waystar Holding Corp. (0001990354) (Issuer)
Chief Technology Officer Schremser Christopher L. exercised 8,623 shares at a strike of $4.14 and sold $313,546 worth of shares (8,623 units at $36.36) (SEC Form 4)
4 - Waystar Holding Corp. (0001990354) (Issuer)
Chief Executive Officer Hawkins Matthew J. exercised 46,667 shares at a strike of $4.14 and sold $1,696,730 worth of shares (46,667 units at $36.36) (SEC Form 4)
4 - Waystar Holding Corp. (0001990354) (Issuer)
Chief Legal Officer Packer Gregory R was granted 52,826 shares (SEC Form 4)
4 - Waystar Holding Corp. (0001990354) (Issuer)
SEC Form 144 filed by Waystar Holding Corp.
144 - Waystar Holding Corp. (0001990354) (Subject)
Amendment: SEC Form SCHEDULE 13G/A filed by Waystar Holding Corp.
SCHEDULE 13G/A - Waystar Holding Corp. (0001990354) (Subject)
SEC Form 424B7 filed by Waystar Holding Corp.
424B7 - Waystar Holding Corp. (0001990354) (Filer)
Ardent Health Appoints Robert DeMichiei to Board of Directors
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U
Waystar to Announce First Quarter 2025 Financial Results on April 30, 2025
LEHI, Utah and LOUISVILLE, Ky., April 7, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the first quarter ended March 31, 2025, after market close on Wednesday, April 30, 2025. The company will discuss its financial results on a conference call at 4:30 p.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. The webcast will be arc
Waystar Reports Fourth Quarter and Fiscal Year 2024 Results
Fiscal year 2024 revenue of $944M, up 19% YoY Q4 revenue growth of 18% year-over-year Q4 net income of $19.1 million and non-GAAP net income of $52.1 million Fiscal year 2024 net loss $19.1 million, 62.7% improvement YoY Fiscal year 2024 adjusted EBITDA of $383M, up 15% YoY Q4 net income margin of 8%; adjusted EBITDA margin of 41% LEHI, Utah and LOUISVILLE, Ky., Feb. 18, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2024. "We are please
Waystar to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on February 18, 2025
LEHI, Utah and LOUISVILLE, Ky., Jan. 28, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the fourth quarter and fiscal year ended December 31, 2024, before market open on Tuesday, February 18, 2025. The company will discuss its financial results on a conference call at 8:30 a.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. Th
SEC Form SC 13G filed by Waystar Holding Corp.
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
SEC Form SC 13G filed by Waystar Holding Corp.
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
SEC Form SC 13G filed by Waystar Holding Corp.
SC 13G - Waystar Holding Corp. (0001990354) (Subject)